Skip to main content

Doman Group, LLC

Location
New York, NY
Portfolio Value
Micro $9,501,009
Diversification
Diversified
Filing Date
Dec 31, 2021
Global Rank
#4,884 / 6,774
Top Industry
Drug Manufacturers - General 6.8%
3Y Alpha vs SPY
-2.7%
Period ended 4 years ago
Filed Mar 14, 2022 · 4y

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+66.3%
SPY
+78.1%
Annualised alpha
-2.7%
Max drawdown
−17.1%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

53 positions · as of Dec 31, 2021
Top Position
6.6%
of portfolio value
Top 5
24.0%
of portfolio value
Top 10
40.1%
of portfolio value
HHI
283
Diversified

Sector Breakdown

As of Dec 31, 2021
Sector % Portfolio Value
Financial Services 22.5% $19,625,822
Technology 20.9% $18,224,079
Communication Services 11.2% $9,798,384
Consumer Defensive 10.9% $9,501,009
Healthcare 10.4% $9,062,573
Consumer Cyclical 9.7% $8,463,232
Industrials 5.5% $4,770,032
Energy 4.6% $3,980,674
Utilities 3.3% $2,841,487
Unclassified 1.2% $1,055,623

Portfolio Positions

Export CSV View 13F filing
6 positions · $9,501,009 total · Consumer Defensive only · as of Dec 31, 2021
Ticker Company Shares Value (USD) % of Portfolio History